ViroCell
ViroCell Biologics manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies (CGTs) to enter clinical trials.
ViroCell Biologics manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies (CGTs) to enter clinical trials.
ViroCell Biologics manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies (CGTs) to enter clinical trials.
Leveraging the team’s 20-year track record of manufacturing more than 100 unique vectors, ViroCell is helping to accelerate the development of crucial, cutting edge therapies so that disease can recede and progress can prevail.
ViroCell is working in partnership with the Royal Free Hospital and Great Ormond Street Hospital.
Website: www.virocell.com
11/11/2022
Long Term Assets Limited ("Long Term Assets" or "LTA"), a Guernsey investment company, today announces its intention to admit its shares to trading ("ITF") on the Specialist Fund Segment of the Main Market of the London Stock Exchange. LTA will then launch a 12-month placing programme, aimed in particular at UK pension funds and other long-term savers. Read more.
10/11/2022
Cyro Cyber has been created to address the dynamic and expanding cyber security requirements of Telent’s core markets across critical national infrastructure, telco service providers and other highly regulated sectors.
01/04/2022
Pension Insurance Corporation Group Limited (“PICG” or the “Company”), ultimate parent company of Pension Insurance Corporation plc (“PIC”), the specialist insurer of defined benefit pension schemes, today announces its final results for the 12 months to 31 December 2021.
17/01/2022
The Pension SuperFund (“PSF”) today announces the appointment of Michael Clark as its Chief Executive Officer (“CEO”). Michael joins PSF from Shell where he has been Global Head of Pensions, responsible for the governance and administration of all the Group’s pension arrangements.
28/12/2021
Telent has announced that it has acquired the Harlequin Group, a specialist technology services company. Complementing Telent’s existing business operations, building telecom infrastructure for mobile network operators (MNO) and service providers, the acquisition significantly enhances its professional services capability in the site acquisition and design arena.
04/10/2021
London, 4 October 2021 – Pension Insurance Corporation plc (“PIC”), a specialist insurer of defined benefit pension funds, has signed a £2.2 billion pension insurance buy-in with the Trustee of the Metal Box Pension Scheme...